Back to Treatments

Treatment

Carboplatin + Paclitaxel (Adjuvant/Palliative Chemotherapy)

1
Conditions
200
Trials
30K
Participants
25%
Average Safety

Condition Evidence

Uterine cancer

200 trials · 30K participants

55% effectiveness · 25% safety
Carboplatin + Paclitaxel (Adjuvant/Palliative Chemotherapy) | DFDA